At this year’s Diversity Site Solutions Summit, SCRS hosted a variety of breakout discussions covering important topics to enable diversity, equity, inclusion and access in clinical trials. Today we’re highlighting some of the takeaways from one of those breakouts, which focused on successful patient recruitment and engagement strategies. Hear from Adrelia Allen from Merck, Deena Bernstein with Datacubed Health, Lacey Clements of IMA Clinical Research and Brittane Strahan from BEKHealth as they share the biggest takeaways and lessons learned from the discussions at the Summit.

In this episode, we explore how to strengthen the relationship between sponsors and CROs and the sites they work with. Mike Wenger, CEO & Founder, VersaTrial, highlights how a single point of contact can help to resolve many bottlenecks.

We also examine how technology can enable this relationship to be more efficient, including the benefits of investing in technology that is "site-ready" and advice for sponsors and CROs looking to make technological investments.

Finally, we delve into why the current CRA model isn't working to achieve the goals of a single point of contact, and what's in it for the sponsor/CRO to prioritize a new approach.

We are thrilled to welcome ProofPilot to the Global Impact Partner (GIP) program! In this episode, Bernadette Tosti, Chief Product Officer at ProofPilot, discusses the importance of listening to site voices in advancing and streamlining clinical research. Bernadette also provides insights into ProofPilot's initiatives and programs and shares how these efforts will impact clinical trial sites. 

In this episode, we're excited to chat about the inaugural SCRS West: Clinical Tech & Innovation Summit coming up in Scottsdale, Arizona. Ramy Nassar, Founder + Managing Partner, 1000 Days Out, and Karri Venn, COO, Centricity Research explore why an event like this is crucial for the clinical trial industry and what attendees can expect.  Ramy and Karri also share how the industry can collaborate to have more site-focused technology solutions and the importance of sites sharing their experiences with clinical technology in an open, collaborative way.

In this episode, we explore the growing trend of remote clinicians and mobile services in the clinical research landscape. IQVIA has been at the forefront of this trend, and we sit down with Eric Neeley, PhD, PMP Senior Director Research Nursing & Phlebotomy Solutions, to discuss what's working, what still needs work, and what to expect from this emerging field.

Eric also shares their learnings from operationalizing this service and how they handle oversight of protocol deviations, which can be a higher risk in decentralized clinical trials.

In this episode, we focus on the challenges facing the clinical research industry when it comes to hiring and retaining clinical research coordinators. Over the past few years, the industry has seen a noticeable decrease in available clinical research staff, making it imperative for sites to find new ways to attract and train new talent.

To address this need, Susan Landis, Executive Director of the Association of Clinical Research Professionals (ACRP), shared more information about ACRP's Early Talent Training Program, which aims to create onramps for the clinical research profession. 

Kelly, Clark, Head of US Partnerships and Global Site Development from Merck, also discusses the industry's focus on improving diversity within the clinical research profession with the OneTen program, which enables more diverse individuals to enter the research profession.

Join us as we discuss how sites and industry partners can collaborate to develop the next generation of diverse staff.

Taneen Hisgrove, Executive Director, Sites and Patients Center of Excellence at PPD, part of Thermo Fisher Scientific, discusses the site-focused initiatives and programs PPD implemented to earn the 2022 Eagle Award CRO of choice. Taneen shares what receiving the Eagle award means to PPD, takeaways from the Global Summit, and what her organization's focus will be for 2023 and beyond.

Andrew Kimball, Executive Vice President of Strategic Commercial Relationships at Velocity Clinical Research, highlights the growth and initiatives of his organization, which is currently the largest dedicated research site organization in the world. Andrew also shares insight on Velocity's acquisition of Meridian Clinical Research and the benefits of joining a site network.

What is the best way for clinical research sites to find new trials and establish productive industry relationships? Scott Whitt, General Manager of Triad Clinical Trials, discusses business development best practices that have worked for his site, and how sites can develop strategic industry alliances.

Todd Albin, Chief Executive Officer, Cedar Health Research, joins us to discuss a trend many clinical research sites have been experiencing with their budget and CTA negotiations with sponsors.

This episode will highlight how this practice impacts site sustainability, as well as our studies and our patients, and some ways sites and sponsors can come to a mutually beneficial solution.

 Access the SCRS Site Invoiceables Toolkit at myscrs.org/site-invoiceables-toolkit.